InhaleRx Limited Stock Price

ASX:IRX Community·AU$8.0m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

IRX Share Price Performance

AU$0

-0.04 (-100.00%)

AU$0

-0.04 (-100.00%)

AU$0

Wed, 26 Nov 25

Share Pricen/a

IRX Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Low risk with imperfect balance sheet.

3 Risks

0 Rewards

View Full Analysis

InhaleRx Limited Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -0.006
: 100.00%
: -159.03%
: -38.3%

View Full Analysis

About IRX

Founded: 2016
Employees: n/a
CEO: Darryl Davies
WebsiteView website: inhalerx.com.au

InhaleRx Limited, a biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia. It is developing IRX-211 that has completed Phase 1 clinical trial for the treatment of Breakthrough Cancer Pain (BTcP); and IRX-616a that is in preclinical trial for panic disorder (PD). The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is headquartered in Melbourne, Australia.